← All trials
NCT03279393
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 28, 2017
- Primary completion
- Feb 28, 2022
- Completion date
- Feb 28, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Icahn School of Medicine at Mount SinaiLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Harvard UniversityCollaborator
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
- Icahn School of Medicine at Mount SinaiSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.